X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,003 | -13,401 | -7,367 | -33,870 | -22,690 |
| Depreciation Amortization | 77 | 51 | 26 | 190 | 148 |
| Accounts receivable | N/A | N/A | N/A | N/A | 57 |
| Accounts payable and accrued liabilities | 209 | -605 | -563 | -1,169 | 2,342 |
| Other Working Capital | 2,014 | 338 | -153 | 3,420 | 5,709 |
| Other Operating Activity | 1,017 | 1,652 | 1,875 | 3,559 | -530 |
| Operating Cash Flow | $-18,686 | $-11,965 | $-6,182 | $-27,870 | $-14,964 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -40 | -59 |
| Other Investing Activity | 0 | 0 | 0 | 70 | 0 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $30 | $-59 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 4,935 |
| Debt Issued | 0 | N/A | N/A | 6,000 | 685 |
| Debt Repayment | -1,500 | -1,000 | -500 | N/A | -1,750 |
| Common Stock Issued | 7 | 7 | N/A | 9 | N/A |
| Other Financing Activity | 3,335 | -1,160 | -1,160 | 95,251 | 39,044 |
| Financing Cash Flow | $1,842 | $-2,153 | $-1,660 | $101,260 | $42,914 |
| Exchange Rate Effect | N/A | N/A | N/A | 330 | 402 |
| Beginning Cash Position | 27,048 | 27,048 | 27,048 | 3,030 | 3,429 |
| End Cash Position | 10,204 | 12,930 | 19,206 | 76,790 | 31,722 |
| Net Cash Flow | $-16,844 | $-14,118 | $-7,842 | $73,750 | $28,293 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,686 | -11,965 | -6,182 | -27,870 | -14,964 |
| Capital Expenditure | N/A | N/A | N/A | -378 | -59 |
| Free Cash Flow | -18,686 | -11,965 | -6,182 | -28,248 | -15,023 |